Grandfield & Dodd LLC raised its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 1.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 65,834 shares of the semiconductor company’s stock after purchasing an additional 1,142 shares during the period. Synopsys accounts for approximately 1.8% of Grandfield & Dodd LLC’s holdings, making the stock its 16th biggest holding. Grandfield & Dodd LLC’s holdings in Synopsys were worth $32,482,000 at the end of the most recent quarter.
Several other institutional investors also recently modified their holdings of the business. Norges Bank bought a new position in Synopsys in the second quarter valued at approximately $647,964,000. Ameriprise Financial Inc. lifted its stake in shares of Synopsys by 29.1% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after purchasing an additional 585,494 shares during the period. Massachusetts Financial Services Co. MA grew its stake in shares of Synopsys by 177.5% during the third quarter. Massachusetts Financial Services Co. MA now owns 865,987 shares of the semiconductor company’s stock worth $427,269,000 after purchasing an additional 553,924 shares during the period. Ninety One UK Ltd bought a new stake in Synopsys in the third quarter valued at about $249,851,000. Finally, Aspex Management HK Ltd increased its holdings in Synopsys by 106.0% in the second quarter. Aspex Management HK Ltd now owns 645,895 shares of the semiconductor company’s stock valued at $331,137,000 after purchasing an additional 332,364 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Stock Performance
Shares of SNPS stock opened at $509.47 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The company’s 50 day moving average price is $464.74 and its two-hundred day moving average price is $504.52. The company has a market capitalization of $97.47 billion, a P/E ratio of 63.76, a price-to-earnings-growth ratio of 4.35 and a beta of 1.12.
Insider Activity
In related news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares in the company, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Janet Lee sold 250 shares of the business’s stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider owned 11,959 shares in the company, valued at $6,338,270. The trade was a 2.05% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 4,157 shares of company stock worth $1,945,036 in the last three months. Company insiders own 0.62% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on SNPS. BNP Paribas Exane initiated coverage on Synopsys in a research report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 target price for the company. Zacks Research upgraded shares of Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Wall Street Zen upgraded shares of Synopsys from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. Citigroup began coverage on shares of Synopsys in a research report on Monday, November 24th. They set a “buy” rating and a $580.00 price target on the stock. Finally, Needham & Company LLC boosted their price target on shares of Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $553.57.
Read Our Latest Stock Analysis on Synopsys
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Executive Order 14330: Trump’s Biggest Yet
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
